A

Adlai Nortye Ltd
D

ANL

1.36000
USD
-0.08
(-5.56%)
مغلق
حجم التداول
180
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
50,184,364
المقالات

العنوان: Adlai Nortye Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.